MedTrace Logo

Ocular Safety and Usability Study for FYB201 PFS

NCT06708624 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2024-11-27

No results posted yet for this study

Summary

The objective of the study is to assess the ocular safety of the FYB201 pre-filled syringe in terms of preparation and administration by Retina Specialists in the clinical setting.

Conditions

  • Age-Related Macular Degeneration
  • Branch Retinal Vein Occlusion with Macular Edema
  • Central Retinal Vein Occlusion with Macular Edema

Interventions

DRUG

FYB201 0.5 mg (0.05 mL of 10 mg/mL)

IVT administration of FYB201 in a PFS

Sponsors & Collaborators

  • Formycon AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-11
Primary Completion
2024-08-08
Completion
2024-08-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06708624 on ClinicalTrials.gov